Vinva Investment Management’s ResMed RMD Stock Holding History

Vinva Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.24M	Buy	19,291 +3,820	+25%	+$952K	0.05%	227
2025 Q4	$3.76M	Buy	15,471 +8,421	+119%	+$2.15M	0.05%	224
2025 Q3	$1.91M	Sell	7,050 -2,031	-22%	-$555K	0.04%	262
2025 Q2	$2.32M	Sell	9,081 -981	-10%	-$234K	0.06%	232
2025 Q1	$2.21M	Buy	10,062 +1,447	+17%	+$338K	0.09%	215
2024 Q4	$1.98M	Sell	8,615 -12,288	-59%	-$2.96M	0.08%	225
2024 Q3	$5M	Buy	20,903 +14,820	+244%	+$3.31M	0.21%	116
2024 Q2	$1.17M	Buy	6,083 +1,268	+26%	+$257K	0.06%	273
2024 Q1	$954K	Buy	+4,815	New	+$882K	0.05%	295

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vinva Investment Management's RMD Position: Q1 2026 in Review

Vinva Investment Management increased its ResMed (RMD) stake by 25% in Q1 2026, buying an estimated $952K and bringing the position to 19,291 shares worth $4.24M. The position accounts for 0.05% of the portfolio, ranked #227.

Vinva Investment Management first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $5M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Vinva Investment Management held 19,291 shares of ResMed worth $4.24M as of Q1 2026.
Vinva Investment Management bought 3,820 ResMed shares in Q1 2026, an estimated $952K.
ResMed made up 0.05% of Vinva Investment Management's portfolio in Q1 2026, its #227 holding.
Vinva Investment Management first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Vinva Investment Management's ResMed position peaked at $5M in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.